An interventional study of High-touch blood pressure management and Low-touch blood pressure management in Hypertension, Pregnancy Induced, sponsored by Jennifer Lewey, MD, MPH. Recruiting at 3 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-22.
Sponsored by Jennifer Lewey, MD, MPH · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Hypertension, Pregnancy-Induced with a site in United States — 30 open to participants now, 40 under way, 4 of them phase 3. Hypertension, Pregnancy-Induced · United States.
Among the 106 studies in Hypertension, Pregnancy-Induced with a site in United States, this one is the 9th largest by planned enrollment of the 89 interventional ones that give a count, is one of 9 that started in 2026, is one of 51 with no phase, reaches primary completion later than 38 of the 39 other live ones, and was the 100th registered.
262 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 70 are open to participants now.
Browse Hypertension, Pregnancy-Induced studies →30 of the 106 studies in Hypertension, Pregnancy-Induced with a site in United States are open now. Recruiting first, the newest first:
University of Alabama at Birmingham · Sites in United States
Ages 16–56 · Women only
Texas Southern University · Sites in United States
Ages 18–45 · Women only
Wake Forest University Health Sciences · Sites in United States
Ages 18–45 · Women only
Massachusetts General Hospital · Sites in United States
Ages 18–65 · Women only
Women and Infants Hospital of Rhode Island · Sites in United States
Ages 18+ · Women only
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 53 Hypertension, Pregnancy-Induced studies recruiting now, 23 (43%) set no upper age limit and 29 (55%) stop at 75 or younger; 7 take children under 18; 16 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 8 · Phase 3 10 · Phase 4 18
First in 2001; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 770 is above the median of 147 across 174 interventional studies indexed under Hypertension, Pregnancy-Induced.
Median enrollment 120 across the 89 interventional studies, 120 across the 17 observational. Of the 55 that completed or were terminated, 33 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 106 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Jennifer Lewey, MD, MPH as lead sponsor.
Jennifer Lewey, MD, MPH has 1 study filed under Hypertension, Pregnancy-Induced — fewer than ten, so there is no comparison to draw.
14 of the studies in Hypertension, Pregnancy-Induced with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07222852Phase 3Women and Infants Hospital of Rhode IslandCardiovascular Protection After Preeclampsia With Enalapril | 2027-10-15 |
| NCT07356518Wake Forest University Health SciencesTelehealth and Remote Blood Pressure | 2026-12 |
| NCT05676476University of Alabama at BirminghamThe ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy. | 2026-12 |
| NCT06523569Northwestern UniversityMobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy | 2026-12-01 |
| NCT05989581University of Alabama at BirminghamChronic Hypertension and Pregnancy 2 (CHAP2) Pilot Project | 2026-12-31 |
Add all 14 to your calendar (.ics) → With an account.
Among the 106 studies in Hypertension, Pregnancy-Induced with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: High-touch blood pressure management
Other: Low-touch blood pressure management
Twelve weeks of text-based home blood pressure monitoring with BP self-management and team-based care
10 days of text-based home blood pressure monitoring
Mean diastolic blood pressure (DBP)
Assessed by 24-hour ambulatory blood pressure monitor (ABPM)
Time frame: 12 months postpartum
Blood pressure outcome: Mean systolic blood pressure (SBP)
Assessed by 24-hour ambulatory blood pressure monitor (ABPM)
Time frame: 12 months postpartum
Blood pressure outcome: Mean nocturnal DBP
Assessed by ABPM
Time frame: 12 months postpartum
Blood pressure outcome: Mean nocturnal SBP
Assessed by ABPM
Time frame: 12 months postpartum
Blood pressure outcome: Mean DBP
Assessed by home blood pressure monitor and office measurement
Time frame: 12 months postpartum
Chronic Hypertension
Defined as 24-hour mean systolic blood pressure greater than or equal to 12mmHg, mean diastolic blood pressure greater than or equal to 75mmHg as assessed by ABPM or taking BP medication
Time frame: 12 months postpartum
Echocardiogram Outcomes
Patients will all undergo a routine transthoracic echocardiogram. Measurements include: Left ventricle (LV) mass index, Relative wall thickness, mean E/e' ratio, left atrial (LA) volume index, global longitudinal strain.
Time frame: 12 months postpartum
Patient Reported Outcome - Patient Activation Measure
Patient Activation Measure (PAM) is a 10 survey that assesses an individual's knowledge, skills and confidence integral to managing one's own health and healthcare. Scored on a scale from 0-100 that correlates to one of four levels of patient activation. PAM Levels 1 and 2 indicate lower patient activation, while PAM Levels 3 and 4 indicate higher patient activation. Survey will be completed at 3 timepoints: at randomization, 6-10 weeks postpartum, and 12 months postpartum
Time frame: Post-randomization to 1 year postpartum
Patient Reported Outcome - Perceived Stress
Scores from the validated Perceived Stress Scale (PSS-10) will be calculated using standard scoring criteria for each of the 10 items. Higher scores are correlated with more perceived stress. Survey to be completed at randomization, at 6-10 weeks postpartum, and at 1 year postpartum.
Time frame: Post-randomization to 1 year postpartum
Patient Reported Outcome - Self-Efficacy
New General Self-Efficacy Scale is an 8-item measure that assesses how much people believe they can achieve their goals, despite difficulties. Using a 5-point rating scale where 1=strongly disagree and 5=strongly agree, scores are calculated by taking the average of their ratings. Survey to be completed at randomization, at 6-10 weeks postpartum, and at 1 year postpartum.
Time frame: Post randomization to 1 year postpartum
Implementation Outcome: Acceptability of Intervention
Patients will be asked questions to assess the acceptability of the intervention. The questions will be scored on a Likert response scales from 1 to 5. Higher scores represent higher acceptability. Asked at two time points, 6 weeks and 12 months postpartum.
Time frame: From 6 weeks postpartum through 1 year postpartum
Plan to share: Yes
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Oct 2029, 43 months after the start.
Of 91 non-industry interventional studies with no phase under Hypertension, Pregnancy-Induced, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 34. This study's planned 43 months is above that.
Counting every sponsor, half of 92 studies reached it within 24 months; a quarter within 10 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hypertension, Pregnancy-Induced →